La vendita allo scoperto per Australian Oilseeds Hldgs dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Australian Oilseeds Hldgs. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Australian Oilseeds Hldgs (NASDAQ:COOT) Azioni, Report sulle vendite allo scoperto

Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently.

Australian Oilseeds Holdings Limited - Ordinary Shares

Australian Oilseeds Holdings Ltd

Australian Oilseeds Holdings Limited - Warrant

CooTek (Cayman) Inc

Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Taboola.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLA#NASDAQ">TBLA</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.0, along with a high estimate of $5.00 and a low estimate of $5.00. Consistency is reflected as the current average remains at the same level as the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2024/1731081628_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of Taboola.com's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Mark Zgutowicz</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Taboola.com. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Taboola.com compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Taboola.com's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Taboola.com's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TBLA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Taboola.com analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Taboola.com</h2>
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.
<h3>Taboola.com's Economic Impact: An Analysis</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Taboola.com's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 28.96% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Communication Services sector.
Net Margin: Taboola.com's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -1.0%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Taboola.com's ROE excels beyond industry benchmarks, reaching -0.42%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Taboola.com's ROA stands out, surpassing industry averages. With an impressive ROA of -0.26%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.21.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

TBLA

Evaluating Taboola.com: Insights From 6 Financial Analysts

WIIM

RXST

RxSight shares are trading lower. The company reported Q3 financial results.

Oppenheimer analyst Suraj Kalia maintains Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) with a Outperform and raises the price target from $30 to $32.

News

Price Target

AORT

Oppenheimer Maintains Outperform on Artivion, Raises Price Target to $32

ASPCU

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Oppenheimer analyst Colin Rusch maintains Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Outperform and lowers the price target from $17 to $14.

ARRY

Oppenheimer Maintains Outperform on Array Technologies, Lowers Price Target to $14

Wedbush analyst Jay McCanless maintains Redfin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) with a Neutral and raises the price target from $8 to $10.

RDFN

Wedbush Maintains Neutral on Redfin, Raises Price Target to $10

Oppenheimer analyst Tyler Batory reiterates Apple Hospitality REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APLE#NYSE">APLE</a>) with a Outperform and raises the price target from $17 to $18.

Reiteration

APLE

Oppenheimer Reiterates Outperform on Apple Hospitality REIT, Raises Price Target to $18

The German State Criminal Police (LKA) has dismissed reports claiming OneCoin founder Ruja Ignatova was murdered, suggesting the notorious &#8220;Crypto Queen&#8221; &#8211; responsible for a $4 billion cryptocurrency fraud &#8211; may be alive and <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39509963/u-s-offers-5m-reward-for-information-on-crypto-fraudster-ruja-ignatova">hiding in South Africa.</a>
What Happened: Ignatova, who made the FBI&#8217;s Ten Most Wanted Fugitives List in 2022, has been on the run since October 2017 when she fled from Sofia to Athens following her U.S. indictment on charges of wire fraud, money laundering, and securities fraud.
The U.S. State Department maintains a $5 million reward for information leading to her arrest.
LKA Düsseldorf, leading the German investigation, has debunked documents suggesting Ignatova was murdered in 2018 and disposed of in the Ionian Sea. 
&#8220;We assume or are working with the hypothesis that Ruja Ignatova is still alive,&#8221; stated LKA spokeswoman Sabine Dässel, as <a href="https://www.spiegel.de/netzwelt/web/onecoin-deutsche-ermittler-halten-todesmeldung-zu-kryptoqueen-ruja-ignatova-fuer-falsch-a-fc6cd492-c961-4aed-b3dc-f69324597b88">reported</a> by Der Spiegel.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41843928/bitcoin-etfs-saw-record-1-38-billion-inflows-on-thursday">Bitcoin ETFs Saw Record $1.38 Billion Inflows On Thursday</a>
The Bulgarian-born German national allegedly orchestrated one of history&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39139647/was-crypto-queen-ruja-ignatova-murdered-by-a-bulgarian-crime-head">largest fraud schemes</a> through OneCoin Ltd., which she launched in 2014, marketing it as a &#8220;Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) killer.&#8221; 
By 2017, investors worldwide had lost over $4 billion through the fraudulent cryptocurrency investment scheme.
Investigators are now focusing on South Africa, particularly Cape Town&#8217;s wealthy districts, where security sources report possible sightings. 
The area&#8217;s connection to OneCoin deepened after a 2023 incident involving the murder of a Bulgarian criminal who allegedly planned to testify to U.S. investigators.
While some assets have been recovered, including $10 million from London property sales, most investor funds remain unaccounted for. 
What&#8217;s Next: The ongoing investigation into OneCoin&#8217;s collapse and its implications for cryptocurrency regulation will be a key topic at Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19, where industry experts will discuss fraud prevention and investor protection in digital assets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41841793/bitcoin-ethereum-solana-rally-does-not-mean-all-cryptocurrencies-will-moon-10x-research">Bitcoin, Ethereum, Solana Rally Does Not Mean All Cryptocurrencies Will Moon: 10x Research</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

'Crypto Queen' Ruja Ignatova, OneCoin's $4 Billion Fraud Mastermind, Is Alive And In South Africa, German Police Suspects

Wedbush analyst Moshe Katri maintains Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) with a Outperform and raises the price target from $35 to $45.

TOST

Wedbush Maintains Outperform on Toast, Raises Price Target to $45

Oppenheimer analyst Colin Rusch maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Outperform and lowers the price target from $171 to $170.

Oppenheimer Maintains Outperform on Albemarle, Lowers Price Target to $170

ADMA

ADMA Biologics shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 and FY25 revenue guidance.

IOVA

Iovance Biotherapeutics shares are trading lower. The company reported Q3 financial results.

Wedbush analyst Michael Pachter maintains Turtle Beach (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEAR#NASDAQ">HEAR</a>) with a Outperform and raises the price target from $19 to $20.

HEAR

Wedbush Maintains Outperform on Turtle Beach, Raises Price Target to $20

Wedbush analyst Scott Devitt maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Neutral and raises the price target from $37 to $38.

PINS

Wedbush Maintains Neutral on Pinterest, Raises Price Target to $38

Wedbush analyst Scott Devitt maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Outperform and raises the price target from $135 to $155.

ABNB

Wedbush Maintains Outperform on Airbnb, Raises Price Target to $155

Wedbush analyst Daniel Ives maintains Consensus Cloud Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCSI#NASDAQ">CCSI</a>) with a Outperform and raises the price target from $24 to $32.

CCSI

Wedbush Maintains Outperform on Consensus Cloud Solns, Raises Price Target to $32

Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) analysts are cautious on the short-term outlook for the electric vehicle company with supply chain concerns, after the company missed third-quarter revenue and <a href="https://www.benzinga.com/news/earnings/24/11/41825787/rivian-q3-earnings-highlights-revenue-eps-miss-ceo-confident-in-q4-gross-profit-r2-being-fundamenta">earnings per share estimates.</a>
The Rivian Analysts: 
<ul>
<li>Truist analyst Jordan Levy maintained a Hold rating on Rivian with a $12 price target.</li>
<li>Wedbush analyst Daniel Ives maintained an Outperform rating with a $20 price target.</li>
<li>Needham analyst Chris Pierce reiterated a Buy rating and lowered the price target from $18 to $14.</li>
<li>Piper Sandler analyst Alexander Potter maintained an Overweight rating and lowered the price target from $21 to $19.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/equities/24/11/41832998/rivian-draftkings-block-pinterest-and-tesla-why-these-5-stocks-are-on-investors-radars-today">Rivian, Draftkings, Block, Pinterest, And Tesla: Why These 5 Stocks Are On Investors&#8217; Radars Today</a>
Truist on RIVN: Proof of profitability for Rivian's R1 vehicle may be necessary to instill confidence in the R2 launch, Levy said in a new investor note.
"RIVN's third quarter results were mired by the company's previously reported component shortage, though a significant expected 4Q uptick in regulatory credit sales + realization of cost-down from Gen 2 models enabled the company to reiterate its 4Q positive GM (gross margin) target," Levy said.
The analyst said Rivian needs to demonstrate consistent profitability to help investors gain confidence.
Rivian's tailwind of resolving supply chain issues was not a surprise to investors, Levy added.
"While we are incrementally positive on the timeline reiteration for R2, we see the recent election results and the incoming administration being an overhang over the entire domestic EV market for the time being given the uncertainty."
Wedbush on RIVN: The electric vehicle company made progress and saw strong demand in the third quarter, but Ives said in a new investor note that there is more work ahead.
Ives said Rivian took two steps forward but one step back as the supply chain challenges hurt the company's plan to ramp up production.
"Rivian did not anticipate such large supply ramp challenges this quarter, however, it should be well sorted over the next few quarters as the company is still on track in terms of timing the R2 production launch," Ives said.
A supply partnership announced with LG on Thursday and the pending launch of the Volkswagen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) joint venture are "critical pieces" for the future of Rivian, Ives added.
"Although we still remain confident in the long-term Rivian vision, it will take some serious strides for the company to regain trust in the short-term vision in the eyes of the Street."
Needham on RIVN: Scale and margins are bearish talking points for the Rivian story, Pierce said in a new investor note.
"We continue to view RIVN as a long-term winner in the eventual ICE to EV transition, leaning on its ability to create a brand and produce vehicles that drive high levels of customer passion and satisfaction," Pierce said.
The analyst said R2 production enhancements are the key focus for 2025 with R2 production set to begin in the first half of 2026. Vehicle profitability for the R2 is expected to be reached faster than the R1 and will be a key factor to watch, the analyst added.
The analyst also highlighted a joint venture with Volkswagen expected to close in the fourth quarter.
"RIVN's balance sheet has been significantly strengthened the Volkswagen announcement, removing any additional equity needs vs our prior model, allowing for a higher level of investor patience."
Piper Sandler on RIVN: The third-quarter results and commentary had no surprises, leading to increasing importance for the joint venture with Volkswagen closing as the next catalyst, Potter said in a new investor note.
"The stock has faltered recently, partially due to slower production, and partially (in our view) because a JV with Volkswagen has yet to be finalized," Potter said.
The analyst said the joint venture terms could continue to be a story in the coming weeks and could see Rivian's valuation expand.
"We will review our model once the JV terms are announced."
RIVN Price Action: Rivian stock is down 0.48% to $10.00 on Friday, versus a 52-week trading range of $8.26 to $24.62. Rivian stock is down 51% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41784487/rivian-lucid-stocks-sink-after-trump-win-whats-driving-bearish-move">Rivian, Lucid Stocks Sink After Trump Win: What&#8217;s Driving Bearish Move?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Trading Ideas

RIVN

VWAGY

Rivian Stock 'Long-Term Winner' In Gas-To-Electric Transition: Analyst

DraftKings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) stock initially traded lower on Friday but reversed course and began moving higher after the company reported third-quarter earnings and lowered its guidance for the 2024 fiscal-year after the bell <a href="https://www.benzinga.com//node/41826834">on Thursday</a>.
The Details: In the report, DraftKings reported a loss of 17 cents per share, beating analyst estimates of a loss of 42 cents per share. Furthermore, the company reported sales of $1.09 billion, missing analyst estimates of $1.11 billion. The reported sales figure represents a 38.6% year-over-year increase.
The company announced an increase in Monthly Unique Payers (MUPs) to 3.6 million, a growth of 55% year-over-year. It also reported Average Revenue per MUPs (ARPMUP) of $103, a 10% decrease compared to the same period last year.
&#8220;We achieved healthy results across our core value drivers in the&nbsp;third quarter&nbsp;with efficient customer acquisition and promotional reinvestment as well as improvement in our structural sportsbook hold percentage,&#8221; said Alan Ellingson, DraftKings&#8217; CFO. 
DraftKings revised its outlook for the 2024 fiscal-year. Specifically, it lowered its revenue guidance from between $5.05 billion and $5.25 billion to between $4.85 billion and $4.95 billion versus analyst estimates of $5.13 billion.
The company also introduced guidance for the 2025 fiscal-year. It anticipates revenue between $6.2 billion and $6.5 billion and adjusted EBITDA between $900 million and $1.0 billion.
Related Link: <a href="https://www.benzinga.com/news/24/11/41808861/whats-going-on-with-palantir-stock-thursday">What&#8217;s Going On With Palantir Stock Thursday?</a>
DKNG Price Action: At the time of publication, DraftKings shares are moving 5.05% higher at $40.95 , according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock

Movers

DKNG

What's Going On With DraftKings Stock Friday?

BMO Capital analyst Tamy Chen maintains Lion Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEV#NYSE">LEV</a>) with a Market Perform and lowers the price target from $0.8 to $0.6.

BMO Capital Maintains Market Perform on Lion Electric, Lowers Price Target to $0.6

BMO Capital analyst James Thalacker maintains Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Outperform and lowers the price target from $298 to $291.

BMO Capital Maintains Outperform on Constellation Energy, Lowers Price Target to $291

Australian Oilseeds Holdings (COOT) has issued an update. In a significant move within the financial markets, EDOC completed a business combination...

Australian Oilseeds Holdings' Strategic Financial Overhaul

Yatsen Holding, 22nd Century among consumer staples movers

TAL Education and Mama's Creations among Consumer Staples movers

APEV, PACB and BILI are among premarket gainers

Lifeway Foods and SNDL among Consumer Staples movers

Andersons and Grand Canyon among Consumer Staples movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning!



Moving stocks today are a new patent, new agreements, delisting news, a proposed public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Agrify (NASDAQ:<a href="https://investorplace.com/stock-quotes/agfy-stock-quote/">AGFY</a>) stock is rocketing more than 56% alongside heavy pre-market trading.</li>



<li>Sunrise New Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/epow-stock-quote/">EPOW</a>) shares are soaring over 36% after being <a href="https://www.nasdaq.com/press-release/sunrise-new-energys-lithium-ion-battery-patent-granted-key-funding-guizhou-province">granted a new battery patent funding</a>.</li>



<li>GRI Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/">GRI</a>) stock is surging close to 32% without any clear news this morning.</li>



<li>Roadzen (NASDAQ:<a href="https://investorplace.com/stock-quotes/rdzn-stock-quote/">RDZN</a>) shares are gaining more than 27% with heavy early morning trading today.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is increasing over 23% despite a lack of news this morning.</li>



<li>Delta Apparel (NYSEMKT:<a href="https://investorplace.com/stock-quotes/dla-stock-quote/">DLA</a>) shares are heading more than 19% higher on Monday morning.</li>



<li>Unusual Machines (NYSEMKT:<a href="https://investorplace.com/stock-quotes/umac-stock-quote/">UMAC</a>) stock is rising 19% <a href="https://www.nasdaq.com/press-release/correction-source-unusual-machines-selected-provide-first-drone-red-cats-fangtm-line">on a drone agreement</a>.</li>



<li>Bitcoin Depot (NASDAQ:<a href="https://investorplace.com/stock-quotes/btm-stock-quote/">BTM</a>) shares are climbing over 15% this morning.</li>



<li>Australian Oilseeds (NASDAQ:<a href="https://investorplace.com/stock-quotes/coot-stock-quote/">COOT</a>) stock is jumping 15% on a <a href="https://www.nasdaq.com/press-release/australian-oilseeds-holdings-limited-announces-launch-new-investment-relationship">new investment relationship</a>.</li>



<li>Denali Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/deca-stock-quote/">DECA</a>) shares are up more than 14% on Monday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>BitFuFu (NASDAQ:<a href="https://investorplace.com/stock-quotes/fufu-stock-quote/">FUFU</a>) stock is diving over 27% after a major rally on Friday.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) shares are tumbling more than 25% ahead of its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318404814&amp;type=PDF&amp;symbol=DMTK&amp;cdn=2f95604b7d0b2db1ef0d52c1cc04ae14&amp;companyName=DermTech+Inc&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-20">delisting later this week</a>.</li>



<li>American Rebel (NASDAQ:<a href="https://investorplace.com/stock-quotes/areb-stock-quote/">AREB</a>) stock is taking a 25% beating <a href="https://www.nasdaq.com/press-release/american-rebel-signs-distribution-agreement-dichello-distributors-state-connecticut">following a Friday rally</a>.</li>



<li>36KR (NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/">KRKR</a>) shares are retreating over 17% after jumping in the <a href="https://investorplace.com/2024/06/why-is-36kr-krkr-stock-up-17-today/">previous day of trading</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) stock is sliding more than 17% as it <a href="https://investorplace.com/2024/06/why-is-professional-diversity-network-ipdn-stock-down-22-today/">continues negative movement</a>.</li>



<li>G1 Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/gthx-stock-quote/">GTHX</a>) shares are falling nearly 17% alongside a <a href="https://www.nasdaq.com/press-release/g1-therapeutics-provides-update-phase-3-preserve-2-trial-patients-receiving">Phase 3 clinical trial update</a>.</li>



<li>Allarity Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) stock is dropping over 16% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318408657&amp;type=PDF&amp;symbol=ALLR&amp;cdn=2b98061f2188998b482fa6052ee2392c&amp;companyName=Allarity+Therapeutics+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-06-21">shareholder meeting plans</a>.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) shares are decreasing more than 14% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318408996&amp;type=PDF&amp;symbol=SPEC&amp;cdn=3890204bdd59982142fb7ff1035bfa7b&amp;companyName=Spectaire+Holdings+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2024-06-21">proposed public offering</a>.</li>



<li>Inuvo (NYSEMKT:<a href="https://investorplace.com/stock-quotes/inuv-stock-quote/">INUV</a>) stock is slipping over 14% today.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) shares close out our pre-market stock movers down more than 13% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-24th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Australian Oilseeds Holdings (COOT) has released an update. Australian Oilseids Holdings Limited has announced the appointment of BDO Audit Pty Ltd...

Australian Oilseeds Appoints New Auditor

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks this morning are earnings reports, a failed merger deal, delisting updates and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>VSee Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock is rocketing more than 159% as the robot maker <a href="https://www.nasdaq.com/press-release/vsee-health-and-ava-robotics-partner-develop-telepresence-solutions-hospital">plans for telepresence solutions</a> for the inpatient intensive care market.</li>



<li>Adagio Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/adgm-stock-quote/">ADGM</a>) shares are soaring close to 36% following its <a href="https://www.businesswire.com/news/home/20240731222906/en/Adagio-Medical-Announces-the-Closing-of-the-Business-Combination-with-ARYA-IV-Creating-a-Publicly-Traded-Company-Focused-on-the-Innovative-Technologies-for-Treatment-of-Cardiac-Arrhythmias">recent public debut</a>.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock is surging over 35% alongside heavy pre-market trading.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) shares are gaining more than 29% on a <a href="https://www.businesswire.com/news/home/20240801299565/en/Exicure-Inc.-Receives-Positive-Listing-Determination-from-Nasdaq">positive listing update</a> from the Nasdaq Capital Market.</li>



<li>Australian Oilseeds (NASDAQ:<a href="https://investorplace.com/stock-quotes/coot-stock-quote/">COOT</a>) stock is rising 25% after announcing a <a href="https://www.nasdaq.com/press-release/australian-oilseeds-announces-appointment-new-independent-auditor-2024-08-01">new independent auditor</a>.</li>



<li>Tandem Diabetes Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/tndm-stock-quote/">TNDM</a>) shares are increasing nearly 25% with the release of its <a href="https://www.nasdaq.com/press-release/tandem-diabetes-care-announces-second-quarter-2024-financial-results-and-increases">Q2 earnings report</a>.</li>



<li>Vaccinex (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcnx-stock-quote/">VCNX</a>) stock is heading over 23% higher with <a href="https://www.nasdaq.com/press-release/vaccinex-reports-positive-data-signal-ad-phase-1b-2-trial-pepinemab-alzheimers">recent clinical trial news</a>.</li>



<li>AGBA Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) shares are climbing more than 13% without any clear news this morning.</li>



<li>Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) stock is jumping over 13% on Friday morning.</li>



<li>Integral Ad Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/ias-stock-quote/">IAS</a>) shares are up 13% with its <a href="https://www.nasdaq.com/press-release/ias-reports-second-quarter-2024-financial-results-2024-08-01">latest earnings news</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is plummeting almost 47% <a href="https://www.pr.com/press-release/917157#:~:text=(Nasdaq%3AGPAK)%20(GPAK,and%20that%20trading%20of%20the">alongside a delisting notice</a>.</li>



<li>Fresh Vine Wine (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vine-stock-quote/">VINE</a>) shares are diving more than 37% with the <a href="https://www.nasdaq.com/press-release/fresh-vine-wine-inc-and-notes-live-inc-mutually-agree-terminate-merger-agreement-2024">termination of a merger agreement</a>.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) stock is tumbling over 30% as Badcock Home Furniture &amp; More <a href="https://nypost.com/2024/08/01/business/major-furniture-chain-badcock-to-shut-all-its-stores-after-120-years/">shuts down all of its stores</a>.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are taking a more than 24% beating on plans for a <a href="https://www.stocktitan.net/news/GNLN/greenlane-announces-board-s-approval-of-reverse-stock-split-9yehmvs5r4ed.html">reverse stock split</a>.</li>



<li>Procore Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/pcor-stock-quote/">PCOR</a>) stock is dropping 22% alongside its <a href="https://www.nasdaq.com/press-release/procore-announces-second-quarter-2024-financial-results-2024-08-01">Q2 earnings report</a>.</li>



<li>Estrella Immunopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/esla-stock-quote/">ESLA</a>) shares are sliding close to 21% on Friday morning.</li>



<li>Intel (NASDAQ:<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>) stock is falling over 20% after releasing its <a href="https://www.theverge.com/2024/8/1/24210656/intel-is-laying-off-over-10000-employees-and-will-cut-10-billion-in-costs">Q2 earnings report</a>.</li>



<li>Smith Micro Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/smsi-stock-quote/">SMSI</a>) shares are decreasing more than 19% with its <a href="https://seekingalpha.com/article/4709513-smith-micro-software-inc-smsi-q2-2024-earnings-call-transcript">latest earnings report</a>.</li>



<li>GraniteShares 2x Long AMZN Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/amzz-stock-quote/">AMZZ</a>) stock is slipping over 17%.</li>



<li>Snap (NYSE:<a href="https://investorplace.com/stock-quotes/snap-stock-quote/">SNAP</a>) shares close out our pre-market stock movers down more than 17% <a href="https://www.cnbc.com/2024/08/01/snap-shares-plunge-over-20percent-af.html">on weak guidance</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Australian Oilseeds Holdings (COOT) has released an update. Australian Oilseeds Holdings Limited has been notified by Nasdaq of non-compliance with...

Australian Oilseeds Faces Nasdaq Compliance Challenge

ADGM

AGBA

AGFY

AKAN

ALLR

AMBO

AMZZ

ANDE

APEI

AREB

BCSA

BILI

BRFH

BRFS

BTTR

CONN

COOT

DECA

DMTK

DTCK

EDBL

EPOW

ESLA

FRPT

FUFU

GNLN

GPAK

GTHX

HKIT

HOLO

INTC

INUV

IPAR

IPDN

KRKR

LICN

LINC

LOPE

LWAY

MAMA

MLGO

MNSO

MOLN

NATR

NIVF

PACB

PCOR

RDZN

SHOT

SMFL

SMSI

SNAP

SNAX

SNDL

SPEC

STRA

TNDM

UMAC

VCNX

VERO

VINE

VSEE

XCUR

XPEV

XXII

ZVIA

Press Releases

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non-GMO "Cold-Processing" Vegetable Oil, Completes Transaction and Will Begin Trading on Nasdaq

Australian Oilseeds Announces Ringing of the NASDAQ Closing Bell to Celebrate Milestone

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non- GMO "Cold-Processing" Vegetable Oil, Expands Australian Operations to the United States

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non-GMO "Cold-Processing" Vegetable Oil, Enters into Contract with Woolworths and Costco Australia.

Australian Oilseeds Announces First Shipment of Sustainable Canola Oil to Neste

Australian Oilseeds Holdings Limited Announces Launch of New Investment Relationship Section on Official Website

Management

Local Business Owner Kevin Chen Named to NSBA Leadership Council

Australian Oilseeds Announces Appointment of New Independent Auditor

Events

Sidoti Events, LLC's Virtual August Micro-Cap Conference

Australian Oilseeds Announces Attendance at Sidoti Micro-Cap Investor Conference

Comments

Australian Oilseeds Hldgs

Vendite allo scoperto

Australian Oilseeds Hldgs (NASDAQ:COOT) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO